{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:48:51Z","timestamp":1784191731660,"version":"3.55.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T00:00:00Z","timestamp":1305849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12016-011-8271-1","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T03:05:16Z","timestamp":1305774316000},"page":"213-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cutting Edge Issues in Rheumatic Fever"],"prefix":"10.1007","volume":"42","author":[{"given":"Christopher","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,20]]},"reference":[{"key":"8271_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1474-4422(10)70096-X","volume":"9","author":"The Lancet Neurology","year":"2010","unstructured":"The Lancet Neurology (2010) Neurological burden of acute rheumatic fever and rheumatic heart disease: the case for action. Lancet Neurol 9:447","journal-title":"Lancet Neurol"},{"key":"8271_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11926-996-0016-4","volume":"3","author":"E Rullan","year":"2001","unstructured":"Rullan E, Sigal LH (2001) Rheumatic fever. Curr Rheumatol Rep 3:445\u2013452","journal-title":"Curr Rheumatol Rep"},{"key":"8271_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.autrev.2009.04.002","volume":"9","author":"JL Lee","year":"2009","unstructured":"Lee JL, Naguwa SM, Cheema GS, Gershwin ME (2009) Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmun Rev 9:117\u2013123","journal-title":"Autoimmun Rev"},{"key":"8271_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/NEJM196003242621204","volume":"262","author":"EF Bland","year":"1960","unstructured":"Bland EF (1960) Declining severity of rheumatic fever. A comparative study of the past four decades. N Engl J Med 262:597\u2013599","journal-title":"N Engl J Med"},{"issue":"2","key":"8271_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/rheumatology\/keq290","volume":"50","author":"S Pastore","year":"2010","unstructured":"Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L (2010) The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford) 50(2):396\u2013400","journal-title":"Rheumatology (Oxford)"},{"key":"8271_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0022-3476(94)70247-0","volume":"124","author":"LG Veasy","year":"1994","unstructured":"Veasy LG, Tani LY, Hill HR (1994) Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 124:9\u201316","journal-title":"J Pediatr"},{"key":"8271_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJM198702193160801","volume":"316","author":"LG Veasy","year":"1987","unstructured":"Veasy LG, Wiedmeier SE, Orsmond GS et al (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316:421\u2013427","journal-title":"N Engl J Med"},{"key":"8271_CR8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.CIR.14.6.1144","volume":"14","author":"EA Mortimer Jr","year":"1956","unstructured":"Mortimer EA Jr, Rammelkamp CH Jr (1956) Prophylaxis of rheumatic fever. Circulation 14:1144\u20131152","journal-title":"Circulation"},{"key":"8271_CR9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1136\/hrt.2007.141309","volume":"94","author":"KB Tibazarwa","year":"2008","unstructured":"Tibazarwa KB, Volmink JA, Mayosi BM (2008) Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 94:1534\u20131540","journal-title":"Heart"},{"key":"8271_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685\u2013694","journal-title":"Lancet Infect Dis"},{"key":"8271_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/INF.0b013e3181bf53f3","volume":"29","author":"J Carapetis","year":"2010","unstructured":"Carapetis J, Steer A (2010) Prevention of rheumatic fever. Pediatr Infect Dis J 29:91\u201392, author reply 2","journal-title":"Pediatr Infect Dis J"},{"key":"8271_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.0954-6820.1988.tb19631.x","volume":"224","author":"S Hoffmann","year":"1988","unstructured":"Hoffmann S, Henrichsen J, Schmidt K (1988) Incidence and diagnosis of acute rheumatic fever in Denmark, 1980 and 1983. A retrospective analysis of the fulfillment of the revised Jones criteria in hospitalized patients. Acta Med Scand 224:587\u2013594","journal-title":"Acta Med Scand"},{"key":"8271_CR13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/B978-1-4160-4044-6.50040-6","volume-title":"Feigen and Cherry\u2019s Textbook of Pediatric Infectious Diseases","author":"D Lennon","year":"2009","unstructured":"Lennon D (2009) In: Feigen R, Cherry JD, Demmier-Harrison GJ, Kaplan SL (eds) Feigen and Cherry\u2019s Textbook of Pediatric Infectious Diseases, 6th edn. Saunders, Philadelphia, pp 419\u2013434","edition":"6"},{"key":"8271_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpeds.2006.03.006","volume":"149","author":"JM Martin","year":"2006","unstructured":"Martin JM, Barbadora KA (2006) Continued high caseload of rheumatic fever in western Pennsylvania: possible rheumatogenic emm types of streptococcus pyogenes. J Pediatr 149:58\u201363","journal-title":"J Pediatr"},{"key":"8271_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.80.3.371","volume":"80","author":"ER Wald","year":"1987","unstructured":"Wald ER, Dashefsky B, Feidt C, Chiponis D, Byers C (1987) Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 80:371\u2013374","journal-title":"Pediatrics"},{"key":"8271_CR16","first-page":"206","volume":"51","author":"LT Chun","year":"1992","unstructured":"Chun LT, Reddy DV, Yim GK, Yamamoto LG (1992) Acute rheumatic fever in Hawaii: 1966 to 1988. Hawaii Med J 51:206\u2013211","journal-title":"Hawaii Med J"},{"key":"8271_CR17","first-page":"519","volume":"37","author":"Centers for Disease Control","year":"1988","unstructured":"Centers for Disease Control (1988) Acute rheumatic fever among Army trainees\u2014Fort Leonard Wood, Missouri, 1987\u20131988. MMWR Morb Mortal Wkly Rep 37:519\u2013522","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8271_CR18","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.1988.03720120010009","volume":"259","author":"Leads from the MMWR","year":"1988","unstructured":"Leads from the MMWR (1988) Acute rheumatic fever at a Navy training center\u2014San Diego, California. JAMA 259:1782\u20131787","journal-title":"JAMA"},{"key":"8271_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/rheumatology\/keq290","volume":"50","author":"S Pastore","year":"2011","unstructured":"Pastore S, De Cunto A, Benettoni A, Berton E, Taddio A, Lepore L (2011) The resurgence of rheumatic fever in a developed country area: the role of echocardiography. Rheumatology (Oxford) 50:396\u2013400","journal-title":"Rheumatology (Oxford)"},{"key":"8271_CR20","first-page":"201","volume":"41","author":"R Olgunturk","year":"1999","unstructured":"Olgunturk R, Aydin GB, Tunaoglu FS, Akalin N (1999) Rheumatic heart disease prevalence among schoolchildren in Ankara, Turkey. Turk J Pediatr 41:201\u2013206","journal-title":"Turk J Pediatr"},{"key":"8271_CR21","first-page":"78","volume":"12","author":"S Vinker","year":"2011","unstructured":"Vinker S, Zohar E, Hoffman R, Elhayany A (2011) Incidence and clinical manifestations of rheumatic fever: a 6 year community-based survey. Isr Med Assoc J 12:78\u201381","journal-title":"Isr Med Assoc J"},{"key":"8271_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/jech.50.1.62","volume":"50","author":"JS Thakur","year":"1996","unstructured":"Thakur JS, Negi PC, Ahluwalia SK, Vaidya NK (1996) Epidemiological survey of rheumatic heart disease among school children in the Shimla Hills of northern India: prevalence and risk factors. J Epidemiol Community Health 50:62\u201367","journal-title":"J Epidemiol Community Health"},{"key":"8271_CR23","first-page":"573","volume":"12","author":"A Chockalingam","year":"2003","unstructured":"Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V (2003) Current profile of acute rheumatic fever and valvulitis in southern India. J Heart Valve Dis 12:573\u2013576","journal-title":"J Heart Valve Dis"},{"key":"8271_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.hlc.2010.02.019","volume":"19","author":"H White","year":"2011","unstructured":"White H, Walsh W, Brown A et al (2011) Rheumatic heart disease in indigenous populations. Heart Lung Circ 19:273\u2013281","journal-title":"Heart Lung Circ"},{"key":"8271_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S0950268800003514","volume":"124","author":"JR Carapetis","year":"2000","unstructured":"Carapetis JR, Currie BJ, Mathews JD (2000) Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 124:239\u2013244","journal-title":"Epidemiol Infect"},{"key":"8271_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1440-1754.2010.01841.x","volume":"46","author":"MG Parnaby","year":"2010","unstructured":"Parnaby MG, Carapetis JR (2010) Rheumatic fever in Indigenous Australian children. J Paediatr Child Health 46:527\u2013533","journal-title":"J Paediatr Child Health"},{"key":"8271_CR27","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.ijid.2009.04.003","volume":"14","author":"MD Seckeler","year":"2010","unstructured":"Seckeler MD, Barton LL, Brownstein R (2010) The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 14:e226\u2013e2269","journal-title":"Int J Infect Dis"},{"key":"8271_CR28","first-page":"99","volume":"16","author":"LA Kohler","year":"2010","unstructured":"Kohler LA, Alik T, Kaplan EL, Anderson FL (2010) A pilot study for the primary prevention of rheumatic fever in Kosrae, Federated States of Micronesia. Pac Health Dialog 16:99\u2013108","journal-title":"Pac Health Dialog"},{"key":"8271_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1017\/S095026880700917X","volume":"136","author":"AC Steer","year":"2008","unstructured":"Steer AC, Jenney AJ, Oppedisano F et al (2008) High burden of invasive beta-haemolytic streptococcal infections in Fiji. Epidemiol Infect 136:621\u2013627","journal-title":"Epidemiol Infect"},{"key":"8271_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0167-5273(97)00311-2","volume":"63","author":"B Longo-Mbenza","year":"1998","unstructured":"Longo-Mbenza B, Bayekula M, Ngiyulu R et al (1998) Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 63:287\u2013294","journal-title":"Int J Cardiol"},{"key":"8271_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/INF.0b013e3181edf475","volume":"29","author":"R Bergmark","year":"2010","unstructured":"Bergmark R, Bergmark B, Blander J, Fataki M, Janabi M (2010) Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania. Pediatr Infect Dis J 29:1135\u20131137","journal-title":"Pediatr Infect Dis J"},{"key":"8271_CR32","first-page":"233","volume":"73","author":"AM Abdel-Moula","year":"1998","unstructured":"Abdel-Moula AM, Sherif AA, Sallam SA, Mandil AM, Kassem AS, Zaher SR (1998) Prevalence of rheumatic heart disease among school children in Alexandria, Egypt: a prospective epidemiological study. J Egypt Public Health Assoc 73:233\u2013254","journal-title":"J Egypt Public Health Assoc"},{"key":"8271_CR33","first-page":"88","volume":"53","author":"BF Massell","year":"1962","unstructured":"Massell BF (1962) Factors in the pathogenesis of rheumatic fever recurrences. J Maine Med Assoc 53:88\u201393","journal-title":"J Maine Med Assoc"},{"key":"8271_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00246-010-9814-6","volume":"32","author":"O Ozdemir","year":"2010","unstructured":"Ozdemir O, Oguz D, Atmaca E, Sanli C, Yildirim A, Olgunturk R (2010) Cardiac troponin T in children with acute rheumatic carditis. Pediatr Cardiol 32:55\u201358","journal-title":"Pediatr Cardiol"},{"key":"8271_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0033-3506(64)80005-6","volume":"78","author":"P Szekely","year":"1964","unstructured":"Szekely P, Farmer MB (1964) Rheumatic fever and rheumatic heart disease; natural history and preventive aspects. Public Health 78:78\u201384","journal-title":"Public Health"},{"key":"8271_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1086\/513768","volume":"25","author":"AL Bisno","year":"1997","unstructured":"Bisno AL, Gerber MA, Gwaltney JM Jr (1997) Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 25:574\u2013583","journal-title":"Clin Infect Dis"},{"key":"8271_CR37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1155\/2006\/696018","volume":"17","author":"KR Forward","year":"2006","unstructured":"Forward KR, Haldane D, Webster D, Mills C, Brine C, Aylward D (2006) A comparison between the Strep A Rapid Test Device and conventional culture for the diagnosis of streptococcal pharyngitis. Can J Infect Dis Med Microbiol 17:221\u2013223","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"8271_CR38","first-page":"261","volume":"15","author":"RD Sheeler","year":"2002","unstructured":"Sheeler RD, Houston MS, Radke S, Dale JC, Adamson SC (2002) Accuracy of rapid strep testing in patients who have had recent streptococcal pharyngitis. J Am Board Fam Pract 15:261\u2013265","journal-title":"J Am Board Fam Pract"},{"key":"8271_CR39","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1542\/peds.111.6.e666","volume":"111","author":"KE Gieseker","year":"2003","unstructured":"Gieseker KE, Roe MH, MacKenzie T, Todd JK (2003) Evaluating the American Academy of Pediatrics diagnostic standard for Streptococcus pyogenes pharyngitis: backup culture versus repeat rapid antigen testing. Pediatrics 111:e666\u2013e670","journal-title":"Pediatrics"},{"issue":"4","key":"8271_CR40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/0009922810385675","volume":"50","author":"TO Rogo","year":"2011","unstructured":"Rogo TO, Schwartz RH, Ascher DP (2011) Comparison of the Inverness Medical Acceava Strep A Test With the Genzyme OSOM and Quidel QuickVue Strep A Tests. Clin Pediatr (Phila) 50(4):294\u2013296","journal-title":"Clin Pediatr (Phila)"},{"key":"8271_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/CMR.17.3.571-580.2004","volume":"17","author":"MA Gerber","year":"2004","unstructured":"Gerber MA, Shulman ST (2004) Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev 17:571\u2013580, table of contents","journal-title":"Clin Microbiol Rev"},{"key":"8271_CR42","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1017\/S0950268807008023","volume":"135","author":"MI McDonald","year":"2007","unstructured":"McDonald MI, Towers RJ, Fagan P, Carapetis JR, Currie BJ (2007) Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection. Epidemiol Infect 135:1398\u20131405","journal-title":"Epidemiol Infect"},{"key":"8271_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0065-2776(08)60128-5","volume":"7","author":"JB Zabriskie","year":"1967","unstructured":"Zabriskie JB (1967) Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol 7:147\u2013188","journal-title":"Adv Immunol"},{"key":"8271_CR44","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1086\/656214","volume":"202","author":"NM Ellis","year":"2010","unstructured":"Ellis NM, Kurahara DK, Vohra H et al (2010) Priming the immune system for heart disease: a perspective on group A streptococci. J Infect Dis 202:1059\u20131067","journal-title":"J Infect Dis"},{"key":"8271_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2249.2000.01283.x","volume":"121","author":"D Tontsch","year":"2000","unstructured":"Tontsch D, Pankuweit S, Maisch B (2000) Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol 121:270\u2013274","journal-title":"Clin Exp Immunol"},{"issue":"Pt 5","key":"8271_CR46","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1099\/00221287-146-5-1195","volume":"146","author":"B Beall","year":"2000","unstructured":"Beall B, Gherardi G, Lovgren M, Facklam RR, Forwick BA, Tyrrell GJ (2000) emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 146(Pt 5):1195\u20131209","journal-title":"Microbiology"},{"key":"8271_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1086\/599344","volume":"49","author":"ST Shulman","year":"2009","unstructured":"Shulman ST, Tanz RR, Dale JB et al (2009) Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates. Clin Infect Dis 49:78\u201384","journal-title":"Clin Infect Dis"},{"key":"8271_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0090-1229(05)80019-4","volume":"61","author":"GH Stollerman","year":"1991","unstructured":"Stollerman GH (1991) Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 61:131\u2013142","journal-title":"Clin Immunol Immunopathol"},{"key":"8271_CR49","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0140-6736(96)06364-7","volume":"349","author":"GH Stollerman","year":"1997","unstructured":"Stollerman GH (1997) Rheumatic fever. Lancet 349:935\u2013942","journal-title":"Lancet"},{"key":"8271_CR50","first-page":"1799","volume-title":"Principles and practice of infectious diseases","author":"A Bisno","year":"1995","unstructured":"Bisno A (1995) Non-suppurative poststreptococcal sequelae: rheumatic fever and glomerulonephritis. In: Mandell GB JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1799\u20131810"},{"key":"8271_CR51","first-page":"1786","volume-title":"Principles and practice of infectious diseases","author":"A Bisno","year":"1995","unstructured":"Bisno A (1995) Streptococcus Pyogenes. In: Mandell GB JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1786\u20131799"},{"key":"8271_CR52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1086\/521263","volume":"45","author":"R Cohen-Poradosu","year":"2007","unstructured":"Cohen-Poradosu R, Kasper DL (2007) Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis 45:863\u2013865","journal-title":"Clin Infect Dis"},{"key":"8271_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ics.2005.11.085","volume":"1289","author":"MR Davies","year":"2006","unstructured":"Davies MR, Tran TN, McMillan DJ, Sriprakash KS (2006) Evidence for increased horizontal gene transfers among streptococci from group A streptococcal endemic regions. Int Congr Ser 1289:188\u2013192","journal-title":"Int Congr Ser"},{"key":"8271_CR54","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1084\/jem.167.6.1945","volume":"167","author":"D Bessen","year":"1988","unstructured":"Bessen D, Fischetti VA (1988) Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med 167:1945\u20131950","journal-title":"J Exp Med"},{"key":"8271_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1196\/annals.1381.045","volume":"1107","author":"L Guilherme","year":"2007","unstructured":"Guilherme L, Kalil J (2007) Rheumatic fever: from innate to acquired immune response. Ann NY Acad Sci 1107:426\u2013433","journal-title":"Ann NY Acad Sci"},{"key":"8271_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0896-8411(03)00079-9","volume":"21","author":"G Hernandez-Pacheco","year":"2003","unstructured":"Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM et al (2003) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21:59\u201363","journal-title":"J Autoimmun"},{"key":"8271_CR57","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.molimm.2006.10.001","volume":"44","author":"R Ramasawmy","year":"2007","unstructured":"Ramasawmy R, Fae KC, Spina G et al (2007) Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 44:1873\u20131878","journal-title":"Mol Immunol"},{"key":"8271_CR58","first-page":"139","volume":"8","author":"N Kutukculer","year":"2008","unstructured":"Kutukculer N, Karaca NE, Sozeri BY et al (2008) Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever. Anadolu Kardiyol Derg 8:139\u2013142","journal-title":"Anadolu Kardiyol Derg"},{"key":"8271_CR59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00246-006-0002-7","volume":"28","author":"A Settin","year":"2007","unstructured":"Settin A, Abdel-Hady H, El-Baz R, Saber I (2007) Gene polymorphisms of TNF-alpha(\u2212308), IL-10(\u22121082), IL-6(\u2212174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28:363\u2013371","journal-title":"Pediatr Cardiol"},{"key":"8271_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08916930500484674","volume":"39","author":"L Guilherme","year":"2006","unstructured":"Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39:31\u201339","journal-title":"Autoimmunity"},{"key":"8271_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1196\/annals.1361.054","volume":"1051","author":"L Guilherme","year":"2005","unstructured":"Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J (2005) Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Ann NY Acad Sci 1051:132\u2013140","journal-title":"Ann NY Acad Sci"},{"key":"8271_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI7132","volume":"106","author":"JE Galvin","year":"2000","unstructured":"Galvin JE, Hemric ME, Ward K, Cunningham MW (2000) Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 106:217\u2013224","journal-title":"J Clin Invest"},{"key":"8271_CR63","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/iai.65.6.2197-2205.1997","volume":"65","author":"M El-Demellawy","year":"1997","unstructured":"El-Demellawy M, El-Ridi R, Guirguis NI, Abdel Alim M, Kotby A, Kotb M (1997) Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect Immun 65:2197\u20132205","journal-title":"Infect Immun"},{"key":"8271_CR64","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.4049\/jimmunol.175.8.5448","volume":"175","author":"NM Ellis","year":"2005","unstructured":"Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW (2005) T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 175:5448\u20135456","journal-title":"J Immunol"},{"key":"8271_CR65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/318076","volume":"183","author":"S Roberts","year":"2001","unstructured":"Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW (2001) Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 183:507\u2013511","journal-title":"J Infect Dis"},{"key":"8271_CR66","doi-asserted-by":"publisher","first-page":"s533","DOI":"10.2741\/1067","volume":"8","author":"MW Cunningham","year":"2003","unstructured":"Cunningham MW (2003) Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 8:s533\u2013s543","journal-title":"Front Biosci"},{"key":"8271_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10067-010-1447-x","volume":"30","author":"R Olgunturk","year":"2011","unstructured":"Olgunturk R, Okur I, Cirak MY et al (2011) The role of viral agents in aetiopathogenesis of acute rheumatic fever. Clin Rheumatol 30:15\u201320","journal-title":"Clin Rheumatol"},{"key":"8271_CR68","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm892","volume":"9","author":"CA Kirvan","year":"2003","unstructured":"Kirvan CA, Swedo SE, Heuser JS, Cunningham MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914\u2013920","journal-title":"Nat Med"},{"key":"8271_CR69","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.4049\/jimmunol.178.11.7412","volume":"178","author":"CA Kirvan","year":"2007","unstructured":"Kirvan CA, Cox CJ, Swedo SE, Cunningham MW (2007) Tubulin is a neuronal target of autoantibodies in Sydenham\u2019s chorea. J Immunol 178:7412\u20137421","journal-title":"J Immunol"},{"key":"8271_CR70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0165-5728(03)00034-1","volume":"136","author":"HS Singer","year":"2003","unstructured":"Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136:154\u2013161","journal-title":"J Neuroimmunol"},{"key":"8271_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08916930500484757","volume":"39","author":"CA Kirvan","year":"2006","unstructured":"Kirvan CA, Swedo SE, Kurahara D, Cunningham MW (2006) Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham\u2019s chorea. Autoimmunity 39:21\u201329","journal-title":"Autoimmunity"},{"key":"8271_CR72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/mds.20052","volume":"19","author":"HS Singer","year":"2004","unstructured":"Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH (2004) Anti-basal ganglia antibodies in PANDAS. Mov Disord 19:406\u2013415","journal-title":"Mov Disord"},{"key":"8271_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-5728(03)00012-2","volume":"136","author":"AJ Church","year":"2003","unstructured":"Church AJ, Dale RC, Cardoso F et al (2003) CSF and serum immune parameters in Sydenham\u2019s chorea: evidence of an autoimmune syndrome? J Neuroimmunol 136:149\u2013153","journal-title":"J Neuroimmunol"},{"key":"8271_CR74","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.humimm.2010.01.007","volume":"71","author":"KC Torres","year":"2010","unstructured":"Torres KC, Dutra WO, de Rezende VB, Cardoso F, Gollob KJ, Teixeira AL (2010) Monocyte dysfunction in Sydenham\u2019s chorea patients. Hum Immunol 71:351\u2013354","journal-title":"Hum Immunol"},{"key":"8271_CR75","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1086\/444458","volume":"41","author":"SA McNeil","year":"2005","unstructured":"McNeil SA, Halperin SA, Langley JM et al (2005) Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 41:1114\u20131122","journal-title":"Clin Infect Dis"},{"key":"8271_CR76","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.150.10.4693","volume":"150","author":"A Vashishtha","year":"1993","unstructured":"Vashishtha A, Fischetti VA (1993) Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol 150:4693\u20134701","journal-title":"J Immunol"},{"key":"8271_CR77","doi-asserted-by":"publisher","first-page":"e5147","DOI":"10.1371\/journal.pone.0005147","volume":"4","author":"M Pandey","year":"2009","unstructured":"Pandey M, Batzloff MR, Good MF (2009) Mechanism of protection induced by group A streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection. PLoS ONE 4:e5147","journal-title":"PLoS ONE"},{"key":"8271_CR78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/infdis\/171.3.593","volume":"171","author":"LG Salvadori","year":"1995","unstructured":"Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB (1995) Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis 171:593\u2013600","journal-title":"J Infect Dis"},{"key":"8271_CR79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/498618","volume":"193","author":"H Sabharwal","year":"2006","unstructured":"Sabharwal H, Michon F, Nelson D et al (2006) Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection. J Infect Dis 193:129\u2013135","journal-title":"J Infect Dis"},{"key":"8271_CR80","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.vaccine.2006.11.031","volume":"25","author":"C Olive","year":"2007","unstructured":"Olive C, Schulze K, Sun HK et al (2007) Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein\/SfbI lipid core peptide vaccine formulation. Vaccine 25:1789\u20131797","journal-title":"Vaccine"},{"key":"8271_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1006\/mpat.1994.1057","volume":"17","author":"P Valentin-Weigand","year":"1994","unstructured":"Valentin-Weigand P, Talay SR, Kaufhold A, Timmis KN, Chhatwal GS (1994) The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. Microb Pathog 17:111\u2013120","journal-title":"Microb Pathog"},{"key":"8271_CR82","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0165-5876(02)00021-6","volume":"63","author":"Y Yokoyama","year":"2002","unstructured":"Yokoyama Y, Harabuchi Y (2002) Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice. Int J Pediatr Otorhinolaryngol 63:235\u2013241","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"8271_CR83","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1128\/IAI.69.2.924-930.2001","volume":"69","author":"S Kawabata","year":"2001","unstructured":"Kawabata S, Kunitomo E, Terao Y et al (2001) Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infect Immun 69:924\u2013930","journal-title":"Infect Immun"},{"key":"8271_CR84","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/iai.65.6.2080-2087.1997","volume":"65","author":"Y Ji","year":"1997","unstructured":"Ji Y, Carlson B, Kondagunta A, Cleary PP (1997) Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus. Infect Immun 65:2080\u20132087","journal-title":"Infect Immun"},{"key":"8271_CR85","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1016\/j.vaccine.2004.04.030","volume":"22","author":"PP Cleary","year":"2004","unstructured":"Cleary PP, Matsuka YV, Huynh T, Lam H, Olmsted SB (2004) Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice. Vaccine 22:4332\u20134341","journal-title":"Vaccine"},{"key":"8271_CR86","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1086\/377700","volume":"188","author":"A Shet","year":"2003","unstructured":"Shet A, Kaplan EL, Johnson DR, Cleary PP (2003) Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development. J Infect Dis 188:809\u2013817","journal-title":"J Infect Dis"},{"key":"8271_CR87","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/mpat.1994.1044","volume":"16","author":"V Kapur","year":"1994","unstructured":"Kapur V, Maffei JT, Greer RS, Li LL, Adams GJ, Musser JM (1994) Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 16:443\u2013450","journal-title":"Microb Pathog"},{"key":"8271_CR88","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1128\/IAI.70.4.2166-2170.2002","volume":"70","author":"JB Dale","year":"2002","unstructured":"Dale JB, Chiang EY, Hasty DL, Courtney HS (2002) Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci. Infect Immun 70:2166\u20132170","journal-title":"Infect Immun"},{"key":"8271_CR89","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0264-410X(93)90310-T","volume":"11","author":"JD Chappell","year":"1993","unstructured":"Chappell JD, Stuart JG (1993) Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine. Vaccine 11:643\u2013648","journal-title":"Vaccine"},{"key":"8271_CR90","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0264-410X(90)90138-C","volume":"8","author":"A Stjernquist-Desatnik","year":"1990","unstructured":"Stjernquist-Desatnik A, Kurl DN, Schalen C, Christensen P (1990) Protective effect of heterologous gram-positive vaccine against lethal upper respiratory tract infection with type M50 group A streptococci in mice. Vaccine 8:150\u2013152","journal-title":"Vaccine"},{"key":"8271_CR91","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","volume":"22","author":"AC Steer","year":"2009","unstructured":"Steer AC, Batzloff MR, Mulholland K, Carapetis JR (2009) Group A streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis 22:544\u2013552","journal-title":"Curr Opin Infect Dis"},{"key":"8271_CR92","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2567.1996.d01-754.x","volume":"89","author":"ER Brandt","year":"1996","unstructured":"Brandt ER, Hayman WA, Currie B et al (1996) Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 89:331\u2013337","journal-title":"Immunology"},{"key":"8271_CR93","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S0264-410X(97)00085-6","volume":"15","author":"DC Jackson","year":"1997","unstructured":"Jackson DC, O\u2019Brien-Simpson N, Ede NJ, Brown LE (1997) Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 15:1697\u20131705","journal-title":"Vaccine"},{"key":"8271_CR94","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/1389557013406666","volume":"1","author":"C Olive","year":"2001","unstructured":"Olive C, Toth I, Jackson D (2001) Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies. Mini Rev Med Chem 1:429\u2013438","journal-title":"Mini Rev Med Chem"},{"key":"8271_CR95","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/IAI.71.5.2373-2383.2003","volume":"71","author":"C Olive","year":"2003","unstructured":"Olive C, Batzloff M, Horvath A et al (2003) Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun 71:2373\u20132383","journal-title":"Infect Immun"},{"key":"8271_CR96","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/374800","volume":"187","author":"MR Batzloff","year":"2003","unstructured":"Batzloff MR, Hayman WA, Davies MR et al (2003) Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 187:1598\u20131608","journal-title":"J Infect Dis"},{"key":"8271_CR97","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709\u2013760","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"8271_CR98","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nano.2010.10.002","volume":"7","author":"M Zaman","year":"2011","unstructured":"Zaman M, Skwarczynski M, Malcolm JM et al (2011) Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. Nanomedicine 7(2):168\u2013173","journal-title":"Nanomedicine"},{"key":"8271_CR99","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1086\/505580","volume":"194","author":"C Olive","year":"2006","unstructured":"Olive C, Sun HK, Ho MF et al (2006) Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. J Infect Dis 194:316\u2013324","journal-title":"J Infect Dis"},{"key":"8271_CR100","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","volume":"119","author":"MA Gerber","year":"2009","unstructured":"Gerber MA, Baltimore RS, Eaton CB et al (2009) Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 119:1541\u20131551","journal-title":"Circulation"},{"key":"8271_CR101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MOP.0b013e32833502e7","volume":"22","author":"RS Baltimore","year":"2010","unstructured":"Baltimore RS (2010) Re-evaluation of antibiotic treatment of streptococcal pharyngitis. Curr Opin Pediatr 22:77\u201382","journal-title":"Curr Opin Pediatr"},{"key":"8271_CR102","first-page":"240","volume":"96","author":"BM Mayosi","year":"2006","unstructured":"Mayosi BM (2006) Protocols for antibiotic use in primary and secondary prevention of rheumatic fever. S Afr Med J 96:240","journal-title":"S Afr Med J"},{"key":"8271_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1542\/peds.103.1.47","volume":"103","author":"HM Feder Jr","year":"1999","unstructured":"Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL (1999) Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 103:47\u201351","journal-title":"Pediatrics"},{"key":"8271_CR104","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1136\/bmj.306.6886.1170","volume":"306","author":"P Shvartzman","year":"1993","unstructured":"Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F (1993) Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ 306:1170\u20131172","journal-title":"BMJ"},{"key":"8271_CR105","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/01.inf.0000235678.46805.92","volume":"25","author":"HW Clegg","year":"2006","unstructured":"Clegg HW, Ryan AG, Dallas SD et al (2006) Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J 25:761\u2013767","journal-title":"Pediatr Infect Dis J"},{"key":"8271_CR106","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/adc.2006.113506","volume":"93","author":"DR Lennon","year":"2008","unstructured":"Lennon DR, Farrell E, Martin DR, Stewart JM (2008) Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child 93:474\u2013478","journal-title":"Arch Dis Child"},{"key":"8271_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2261-5-11","volume":"5","author":"KA Robertson","year":"2005","unstructured":"Robertson KA, Volmink JA, Mayosi BM (2005) Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 5:11","journal-title":"BMC Cardiovasc Disord"},{"key":"8271_CR108","doi-asserted-by":"crossref","unstructured":"Manyemba J, Mayosi BM (2002) Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev (3):CD002227","DOI":"10.1002\/14651858.CD002227"},{"key":"8271_CR109","first-page":"135","volume":"19","author":"P Nordet","year":"2008","unstructured":"Nordet P, Lopez R, Duenas A, Sarmiento L (2008) Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986\u20131996\u20132002). Cardiovasc J Afr 19:135\u2013140","journal-title":"Cardiovasc J Afr"},{"key":"8271_CR110","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1440-1754.2010.01854.x","volume":"46","author":"M Kerdemelidis","year":"2010","unstructured":"Kerdemelidis M, Lennon DR, Arroll B, Peat B, Jarman J (2010) The primary prevention of rheumatic fever. J Paediatr Child Health 46:534\u2013548","journal-title":"J Paediatr Child Health"},{"key":"8271_CR111","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5694\/j.1326-5377.2010.tb03641.x","volume":"192","author":"JN Hanna","year":"2011","unstructured":"Hanna JN, Clark MF (2011) Acute rheumatic fever in Indigenous people in North Queensland: some good news at last? Med J Aust 192:581\u2013584","journal-title":"Med J Aust"},{"key":"8271_CR112","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJM197308162890701","volume":"289","author":"L Gordis","year":"1973","unstructured":"Gordis L (1973) Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 289:331\u2013335","journal-title":"N Engl J Med"},{"key":"8271_CR113","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1001\/jama.294.18.2315","volume":"294","author":"JA Linder","year":"2005","unstructured":"Linder JA, Bates DW, Lee GM, Finkelstein JA (2005) Antibiotic treatment of children with sore throat. JAMA 294:2315\u20132322","journal-title":"JAMA"},{"key":"8271_CR114","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1086\/341409","volume":"35","author":"KL O\u2019Brien","year":"2002","unstructured":"O\u2019Brien KL, Beall B, Barrett NL et al (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995\u20131999. Clin Infect Dis 35:268\u2013276","journal-title":"Clin Infect Dis"},{"key":"8271_CR115","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jama.1993.03500030082037","volume":"269","author":"CW Hoge","year":"1993","unstructured":"Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269:384\u2013389","journal-title":"JAMA"},{"key":"8271_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1542\/peds.2007-0484","volume":"121","author":"E Pfoh","year":"2008","unstructured":"Pfoh E, Wessels MR, Goldmann D, Lee GM (2008) Burden and economic cost of group A streptococcal pharyngitis. Pediatrics 121:229\u2013234","journal-title":"Pediatrics"},{"key":"8271_CR117","first-page":"1394","volume":"28","author":"MT Terreri","year":"2001","unstructured":"Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilario MO (2001) Resource utilization and cost of rheumatic fever. J Rheumatol 28:1394\u20131397","journal-title":"J Rheumatol"},{"key":"8271_CR118","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12098-007-0094-y","volume":"74","author":"MB Soudarssanane","year":"2007","unstructured":"Soudarssanane MB, Karthigeyan M, Mahalakshmy T et al (2007) Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J Pediatr 74:567\u2013570","journal-title":"Indian J Pediatr"},{"key":"8271_CR119","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0022-5223(00)70217-0","volume":"119","author":"TM Yau","year":"2000","unstructured":"Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE (2000) Mitral valve repair and replacement for rheumatic disease. J Thorac Cardiovasc Surg 119:53\u201360","journal-title":"J Thorac Cardiovasc Surg"},{"key":"8271_CR120","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/S0140-6736(09)60692-9","volume":"373","author":"M Enriquez-Sarano","year":"2009","unstructured":"Enriquez-Sarano M, Akins CW, Vahanian A (2009) Mitral regurgitation. Lancet 373:1382\u20131394","journal-title":"Lancet"},{"key":"8271_CR121","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/01.CIR.0000079169.15862.13","volume":"108","author":"VH Thourani","year":"2003","unstructured":"Thourani VH, Weintraub WS, Guyton RA et al (2003) Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. Circulation 108:298\u2013304","journal-title":"Circulation"},{"key":"8271_CR122","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.99.12.1580","volume":"99","author":"R Hernandez","year":"1999","unstructured":"Hernandez R, Banuelos C, Alfonso F et al (1999) Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation 99:1580\u20131586","journal-title":"Circulation"},{"key":"8271_CR123","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1161\/01.CIR.99.25.3272","volume":"99","author":"B Iung","year":"1999","unstructured":"Iung B, Garbarz E, Michaud P et al (1999) Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation 99:3272\u20133278","journal-title":"Circulation"},{"key":"8271_CR124","first-page":"478","volume":"20","author":"B Iung","year":"1999","unstructured":"Iung B, Vahanian A (1999) Mid-term results of percutaneous mitral balloon valvotomy. Eur Heart J 20:478\u2013479","journal-title":"Eur Heart J"},{"key":"8271_CR125","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0140-6736(06)68934-4","volume":"367","author":"AC Steer","year":"2006","unstructured":"Steer AC, Kado J, Colquhoun S, Noonan S, Babitu T (2006) Awareness of rheumatic heart disease. Lancet 367:2118","journal-title":"Lancet"},{"key":"8271_CR126","first-page":"49","volume":"13","author":"A Steer","year":"2006","unstructured":"Steer A, Colquhoun S, Noonan S, Kado J, Viale S, Carapetis J (2006) Control of rheumatic heart disease in the Pacific region. Pac Health Dialog 13:49\u201355","journal-title":"Pac Health Dialog"},{"key":"8271_CR127","doi-asserted-by":"publisher","first-page":"A325","DOI":"10.1016\/j.autrev.2009.11.012","volume":"9","author":"M Ehrenfeld","year":"2010","unstructured":"Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9:A325\u2013A329","journal-title":"Autoimmun Rev"},{"key":"8271_CR128","doi-asserted-by":"publisher","first-page":"J307","DOI":"10.1016\/j.jaut.2009.11.019","volume":"34","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves\u2019 disease: evidence of a genetic and an environmental contribution. J Autoimmun 34:J307\u2013J313","journal-title":"J Autoimmun"},{"key":"8271_CR129","doi-asserted-by":"publisher","first-page":"J300","DOI":"10.1016\/j.jaut.2009.12.002","volume":"34","author":"P Invernizzi","year":"2009","unstructured":"Invernizzi P (2009) Geoepidemiology of autoimmune liver diseases. J Autoimmun 34:J300\u2013J306","journal-title":"J Autoimmun"},{"key":"8271_CR130","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258\u2013J265","journal-title":"J Autoimmun"},{"key":"8271_CR131","doi-asserted-by":"publisher","first-page":"A319","DOI":"10.1016\/j.autrev.2009.11.018","volume":"9","author":"Y Berkun","year":"2010","unstructured":"Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319\u2013A324","journal-title":"Autoimmun Rev"},{"key":"8271_CR132","doi-asserted-by":"publisher","first-page":"J234","DOI":"10.1016\/j.jaut.2009.11.009","volume":"34","author":"C Chang","year":"2010","unstructured":"Chang C (2010) The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 34:J234\u2013J246","journal-title":"J Autoimmun"},{"key":"8271_CR133","doi-asserted-by":"publisher","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","volume":"9","author":"M Chen","year":"2010","unstructured":"Chen M, Kallenberg CG (2010) The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 9:A293\u2013A298","journal-title":"Autoimmun Rev"},{"key":"8271_CR134","doi-asserted-by":"publisher","first-page":"A342","DOI":"10.1016\/j.autrev.2009.11.020","volume":"9","author":"S Deane","year":"2010","unstructured":"Deane S, Teuber SS, Gershwin ME (2010) The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 9:A342\u2013A349","journal-title":"Autoimmun Rev"},{"key":"8271_CR135","doi-asserted-by":"publisher","first-page":"A383","DOI":"10.1016\/j.autrev.2009.11.011","volume":"9","author":"A Meyer","year":"2010","unstructured":"Meyer A, Levy Y (2010) Chapter 33: Geoepidemiology of myasthenia gravis. Autoimmun Rev 9:A383\u2013A386","journal-title":"Autoimmun Rev"},{"key":"8271_CR136","doi-asserted-by":"publisher","first-page":"A379","DOI":"10.1016\/j.autrev.2009.10.009","volume":"9","author":"N Meyer","year":"2010","unstructured":"Meyer N, Misery L (2010) Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 9:A379\u2013A382","journal-title":"Autoimmun Rev"},{"key":"8271_CR137","doi-asserted-by":"publisher","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjogren\u2019s syndrome. Autoimmun Rev 9:A305\u2013A310","journal-title":"Autoimmun Rev"},{"key":"8271_CR138","doi-asserted-by":"publisher","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","volume":"9","author":"B Ranque","year":"2010","unstructured":"Ranque B, Mouthon L (2010) Geoepidemiology of systemic sclerosis. Autoimmun Rev 9:A311\u2013A318","journal-title":"Autoimmun Rev"},{"key":"8271_CR139","doi-asserted-by":"publisher","first-page":"A288","DOI":"10.1016\/j.autrev.2009.11.019","volume":"9","author":"GJ Tobon","year":"2010","unstructured":"Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9:A288\u2013A292","journal-title":"Autoimmun Rev"},{"key":"8271_CR140","doi-asserted-by":"publisher","first-page":"A259","DOI":"10.1016\/j.autrev.2009.12.002","volume":"9","author":"A Lleo","year":"2010","unstructured":"Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity\u2014autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259\u2013A266","journal-title":"Autoimmun Rev"},{"key":"8271_CR141","doi-asserted-by":"publisher","first-page":"J220","DOI":"10.1016\/j.jaut.2009.11.007","volume":"34","author":"JL Round","year":"2010","unstructured":"Round JL, O\u2019Connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34:J220\u2013J225","journal-title":"J Autoimmun"},{"key":"8271_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2008.07.014","volume":"8","author":"A Doria","year":"2008","unstructured":"Doria A, Sarzi-Puttini P, Shoenfeld Y (2008) Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 8:1\u20134","journal-title":"Autoimmun Rev"},{"key":"8271_CR143","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12016-007-8048-8","volume":"34","author":"V Pordeus","year":"2008","unstructured":"Pordeus V, Szyper-Kravitz M, Levy RA, Vaz NM, Shoenfeld Y (2008) Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol 34:283\u2013299","journal-title":"Clin Rev Allergy Immunol"},{"key":"8271_CR144","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/art.22708","volume":"56","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro N, Tozzoli R, Shoenfeld Y (2007) Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 56:1736\u20131744","journal-title":"Arthritis Rheum"},{"key":"8271_CR145","doi-asserted-by":"publisher","first-page":"A277","DOI":"10.1016\/j.autrev.2009.12.008","volume":"9","author":"AT Borchers","year":"2010","unstructured":"Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277\u2013A287","journal-title":"Autoimmun Rev"},{"key":"8271_CR146","doi-asserted-by":"publisher","first-page":"A355","DOI":"10.1016\/j.autrev.2009.12.003","volume":"9","author":"AT Borchers","year":"2010","unstructured":"Borchers AT, Uibo R, Gershwin ME (2010) The geoepidemiology of type 1 diabetes. Autoimmun Rev 9:A355\u2013A365","journal-title":"Autoimmun Rev"},{"key":"8271_CR147","doi-asserted-by":"publisher","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","volume":"34","author":"WH Brooks","year":"2010","unstructured":"Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207\u2013J219","journal-title":"J Autoimmun"},{"key":"8271_CR148","doi-asserted-by":"publisher","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","volume":"34","author":"V Chandran","year":"2010","unstructured":"Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314\u2013J321","journal-title":"J Autoimmun"},{"key":"8271_CR149","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-2005-916330","volume":"25","author":"IR Mackay","year":"2005","unstructured":"Mackay IR (2005) The etiopathogenesis of autoimmunity. Semin Liver Dis 25:239\u2013250","journal-title":"Semin Liver Dis"},{"key":"8271_CR150","doi-asserted-by":"publisher","first-page":"J163","DOI":"10.1016\/j.jaut.2009.12.005","volume":"34","author":"P Youinou","year":"2010","unstructured":"Youinou P, Pers JO, Gershwin ME, Shoenfeld Y (2010) Geo-epidemiology and autoimmunity. J Autoimmun 34:J163\u2013J167","journal-title":"J Autoimmun"},{"key":"8271_CR151","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","volume":"31","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325\u2013330","journal-title":"J Autoimmun"},{"key":"8271_CR152","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.autrev.2005.07.003","volume":"5","author":"AY Hershko","year":"2006","unstructured":"Hershko AY, Naparstek Y (2006) Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 5:230\u2013233","journal-title":"Autoimmun Rev"},{"key":"8271_CR153","doi-asserted-by":"publisher","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","volume":"34","author":"Y Shapira","year":"2010","unstructured":"Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168\u2013J177","journal-title":"J Autoimmun"},{"key":"8271_CR154","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.autrev.2009.10.004","volume":"9","author":"PS Leung","year":"2010","unstructured":"Leung PS, Dhirapong A, Wu PY, Tao MH (2010) Gene therapy in autoimmune diseases: challenges and opportunities. Autoimmun Rev 9:170\u2013174","journal-title":"Autoimmun Rev"},{"key":"8271_CR155","first-page":"601","volume":"76","author":"K Oli","year":"1999","unstructured":"Oli K, Porteous J (1999) Prevalence of rheumatic heart disease among school children in Addis Ababa. East Afr Med J 76:601\u2013605","journal-title":"East Afr Med J"},{"key":"8271_CR156","first-page":"279","volume":"54","author":"KL Periwal","year":"2006","unstructured":"Periwal KL, Gupta BK, Panwar RB, Khatri PC, Raja S, Gupta R (2006) Prevalence of rheumatic heart disease in school children in Bikaner: an echocardiographic study. J Assoc Physicians India 54:279\u2013282","journal-title":"J Assoc Physicians India"},{"key":"8271_CR157","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000174993","volume":"80","author":"K Oli","year":"1992","unstructured":"Oli K, Tekle-Haimanot R, Forsgren L, Ekstedt J (1992) Rheumatic heart disease prevalence among schoolchildren of an Ethiopian rural town. Cardiology 80:152\u2013155","journal-title":"Cardiology"},{"key":"8271_CR158","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5694\/j.1326-5377.2009.tb02312.x","volume":"190","author":"AC Steer","year":"2009","unstructured":"Steer AC, Kado J, Jenney AW et al (2009) Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005\u20132007. Med J Aust 190:133\u2013135","journal-title":"Med J Aust"},{"key":"8271_CR159","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/hrt.2008.143982","volume":"95","author":"M Sadiq","year":"2009","unstructured":"Sadiq M, Islam K, Abid R et al (2009) Prevalence of rheumatic heart disease in school children of urban Lahore. Heart 95:353\u2013357","journal-title":"Heart"},{"key":"8271_CR160","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1440-1754.2008.01384.x","volume":"44","author":"R Jaine","year":"2008","unstructured":"Jaine R, Baker M, Venugopal K (2008) Epidemiology of acute rheumatic fever in New Zealand 1996\u20132005. J Paediatr Child Health 44:564\u2013571","journal-title":"J Paediatr Child Health"},{"key":"8271_CR161","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.hlc.2010.02.021","volume":"19","author":"N Wilson","year":"2010","unstructured":"Wilson N (2010) Rheumatic heart disease in indigenous populations\u2014New Zealand experience. Heart Lung Circ 19:282\u2013288","journal-title":"Heart Lung Circ"},{"key":"8271_CR162","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.amjcard.2010.01.364","volume":"105","author":"JA Paar","year":"2010","unstructured":"Paar JA, Berrios NM, Rose JD et al (2010) Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 105:1809\u20131814","journal-title":"Am J Cardiol"},{"key":"8271_CR163","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/hrt.2003.025981","volume":"90","author":"SF Rizvi","year":"2004","unstructured":"Rizvi SF, Khan MA, Kundi A, Marsh DR, Samad A, Pasha O (2004) Status of rheumatic heart disease in rural Pakistan. Heart 90:394\u2013399","journal-title":"Heart"},{"key":"8271_CR164","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/146642409011000107","volume":"110","author":"MA al-Sekait","year":"1990","unstructured":"al-Sekait MA, al-Sweliem AA, Tahir M (1990) Rheumatic heart disease in schoolchildren in western district, Saudi Arabia. J R Soc Health 110:15\u201316, 9","journal-title":"J R Soc Health"},{"key":"8271_CR165","first-page":"518","volume":"49","author":"PR Regmi","year":"1997","unstructured":"Regmi PR, Pandey MR (1997) Prevalence of rheumatic fever and rheumatic heart disease in school children of Kathmandu city. Indian Heart J 49:518\u2013520","journal-title":"Indian Heart J"},{"key":"8271_CR166","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00246-010-9663-3","volume":"31","author":"N El-Hagrassy","year":"2011","unstructured":"El-Hagrassy N, El-Chennawi F, Zaki Mel S, Fawzy H, Zaki A, Joseph N (2011) HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease. Pediatr Cardiol 31:650\u2013656","journal-title":"Pediatr Cardiol"},{"key":"8271_CR167","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/0002-8703(83)90673-7","volume":"106","author":"S Naito","year":"1983","unstructured":"Naito S, Kitajima K, Arakawa K (1983) HLA and rheumatic heart disease in Japanese. Am Heart J 106:1164\u20131167","journal-title":"Am Heart J"},{"key":"8271_CR168","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/0002-8703(86)90311-X","volume":"112","author":"MI Anastasiou-Nana","year":"1986","unstructured":"Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN (1986) HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J 112:992\u2013997","journal-title":"Am Heart J"},{"key":"8271_CR169","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1172\/JCI112531","volume":"77","author":"EM Ayoub","year":"1986","unstructured":"Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP (1986) Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 77:2019\u20132026","journal-title":"J Clin Invest"},{"key":"8271_CR170","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/hrt.58.6.659","volume":"58","author":"CN Rajapakse","year":"1987","unstructured":"Rajapakse CN, Halim K, Al-Orainey I, Al-Nozha M, Al-Aska AK (1987) A genetic marker for rheumatic heart disease. Br Heart J 58:659\u2013662","journal-title":"Br Heart J"},{"key":"8271_CR171","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/01.CIR.83.6.1995","volume":"83","author":"L Guilherme","year":"1991","unstructured":"Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J (1991) Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 83:1995\u20131998","journal-title":"Circulation"},{"key":"8271_CR172","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1161\/01.CIR.99.21.2784","volume":"99","author":"Y Guedez","year":"1999","unstructured":"Guedez Y, Kotby A, El-Demellawy M et al (1999) HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 99:2784\u20132790","journal-title":"Circulation"},{"key":"8271_CR173","doi-asserted-by":"publisher","first-page":"R340","DOI":"10.1186\/ar1000","volume":"5","author":"V Stanevicha","year":"2003","unstructured":"Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R (2003) HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res Ther 5:R340\u2013R346","journal-title":"Arthritis Res Ther"},{"key":"8271_CR174","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.87.6.1974","volume":"87","author":"M Ozkan","year":"1993","unstructured":"Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C (1993) HLA antigens in Turkish race with rheumatic heart disease [see comment]. Circulation 87:1974\u20131978","journal-title":"Circulation"},{"key":"8271_CR175","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0167-5273(03)00040-8","volume":"92","author":"G Hernandez-Pacheco","year":"2003","unstructured":"Hernandez-Pacheco G, Aguilar-Garcia J, Flores-Dominguez C et al (2003) MHC class II alleles in Mexican patients with rheumatic heart disease. Int J Cardiol 92:49\u201354","journal-title":"Int J Cardiol"},{"key":"8271_CR176","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/intimm\/6.8.1235","volume":"6","author":"S Pruksakorn","year":"1994","unstructured":"Pruksakorn S, Currie B, Brandt E et al (1994) Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 6:1235\u20131244","journal-title":"Int Immunol"},{"key":"8271_CR177","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM199701093360202","volume":"336","author":"JA Stoute","year":"1997","unstructured":"Stoute JA, Slaoui M, Heppner DG et al (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N Engl J Med 336:86\u201391","journal-title":"N Engl J Med"},{"key":"8271_CR178","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/74719","volume":"6","author":"ER Brandt","year":"2000","unstructured":"Brandt ER, Sriprakash KS, Hobb RI et al (2000) New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med 6:455\u2013459","journal-title":"Nat Med"},{"key":"8271_CR179","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1462-5822.2000.00076.x","volume":"2","author":"SR Talay","year":"2000","unstructured":"Talay SR, Zock A, Rohde M et al (2000) Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells. Cell Microbiol 2:521\u2013535","journal-title":"Cell Microbiol"},{"key":"8271_CR180","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/314655","volume":"179","author":"CA Guzman","year":"1999","unstructured":"Guzman CA, Talay SR, Molinari G, Medina E, Chhatwal GS (1999) Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J Infect Dis 179:901\u2013906","journal-title":"J Infect Dis"},{"key":"8271_CR181","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1069::AID-IMMU1069>3.0.CO;2-P","volume":"28","author":"E Medina","year":"1998","unstructured":"Medina E, Talay SR, Chhatwal GS, Guzman CA (1998) Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur J Immunol 28:1069\u20131077","journal-title":"Eur J Immunol"},{"key":"8271_CR182","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1086\/595564","volume":"199","author":"I Margarit","year":"2009","unstructured":"Margarit I, Rinaudo CD, Galeotti CL et al (2009) Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 199:108\u2013115","journal-title":"J Infect Dis"},{"key":"8271_CR183","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1086\/593176","volume":"198","author":"F Falugi","year":"2008","unstructured":"Falugi F, Zingaretti C, Pinto V et al (2008) Sequence variation in group A streptococcus pili and association of pilus backbone types with lancefield T serotypes. J Infect Dis 198:1834\u20131841","journal-title":"J Infect Dis"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-011-8271-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8271-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:29:59Z","timestamp":1744169399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-011-8271-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,20]]},"references-count":183,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["8271"],"URL":"https:\/\/doi.org\/10.1007\/s12016-011-8271-1","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,20]]},"assertion":[{"value":"20 May 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}